Quantitative Insight in Utilizing Circulating Angiogenic Factors as Biomarkers for Antiangiogenic Therapy: Systems Pharmacology Approach

Circulating angiogenic factors (CAF) like vascular endothelial growth factor (VEGF), placental growth factor (PlGF), and sVEGFR2 have potential as biomarkers for antiangiogenic therapy. The interpretation of changes in CAF is complicated by the dynamic nature of the tumor and host cells emanating CA...

Descripción completa

Detalles Bibliográficos
Autores principales: Sharan, S, Woo, S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2014
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4474166/
https://www.ncbi.nlm.nih.gov/pubmed/25295574
http://dx.doi.org/10.1038/psp.2014.36

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4474166/
https://www.ncbi.nlm.nih.gov/pubmed/25295574
http://dx.doi.org/10.1038/psp.2014.36

Ejemplares similares